Several studies have shown that loss of expression of the receptor-interacting serine/threonine protein kinase 3 (RIPK3), an essential mediator of necroptotic cell death, promotes the development of cancer, including acute myeloid leukaemia [1]. This evidence concerns the gene RIPK3 and acute myeloid leukemia.